ベータ
治験レーダーAI
治験 NCT04536480(対象:小児肥満、2型糖尿病、時間制限食)は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。
フィルター基準に一致する試験が1件見つかりました
タイル表示

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

募集中
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます!「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT04536480介入研究 臨床試験 で、小児肥満、2型糖尿病、時間制限食 に関するものです。現在は 募集中 で、2023年4月15日 から開始しています。100 名の参加者 の募集が計画されています。この治験は Children's Hospital Los Angeles によって主催され、2027年12月1日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2025年6月24日 です。
概要
To find the effectiveness of a diet plan (Time Limited Eating or TLE) on glycemic control, B-cell function, body fat, and body mass index (BMI) in adolescents with type 2 diabetes.
詳細説明
Intervention Design This is a prospective, pilot randomized controlled trial testing the efficacy of time-limited eating (TLE) on glycemic control, β-cell function, and body composition among predominantly Latinx adolescents with T2D compared to a prolonged eating period (12+hours). One-hundred adolescents with T2D will be recruited from CHLA. All participants will receive standard nutritional counseling and will be randomized to one of two meal-timing schedules to be followed for 12 weeks: (1) Control: 12-hour or more eating window without mealtime restrictions and (2) TLE: 8-hour eating period (16 hours of daily fasting).

The implementation steps of the proposed RCT are as follows:

  1. The staff will introduce the study to all eligible participants either in person or virtually and consent interested families for the study.
  2. All participants and their families will complete baseline study surveys in REDcap.
  3. All participants and their families will receive training on the use and application of the Dexcom G6 CGM, which is FDA approved in patients 2 years and older. All equipment required for the duration of the study will be distributed to the participants in-person. Participants will receive enough sensors to wear the CGM daily for the entire study period. Participants will be instructed to change their sensor every 10 days with the assistance of the study staff. Each participant will be asked to download the CGM app onto their personal smartphone and set up an account with a pseudonym.
  4. All participants and their families will receive standard nutritional counseling and be randomized to one of two meal-timing schedules to be followed for 12 weeks: (1) Control: >12-hour eating or (2) TLE (8-hr eating period/16-hr of daily fasting). During the eating window, participants will not be required to count calories or monitor their food intake. Participants will choose and pay for their own food during the intervention. All participants will record their eating window daily and submit it to the study staff via REDcap. All participants will receive standard recommendations for physical activity, screen, and sleep time as per the American Academy of Pediatrics age appropriate recommendations at the first visit140.
  5. The study staff will perform weekly phone encounters with the participants to assess barriers to adherence and review the CGM data. If a barrier is identified the study staff will create a solution plan to promote adherence and retention. The study staff will record any medication changes or health issues that have occurred in the last 7 days. To foster treatment adherence, participants will receive weekly calls from the study staff for the duration of the trial. Counseling will be conducted by trained research staff. The sessions will serve three purposes: (1) foster adherence, retention, and accountability; (2) troubleshoot intervention barriers; and (3) monitor safety endpoints. During the sessions, participants will be provided with the support, knowledge, skills, and resources they need to successfully adhere to the protocol. The research staff will analyze the adherence data and progress using multiple-pass methodology. To support participants, the staff will use behavioral techniques, such as stimulus control, goal setting, behavioral contracting, and motivational interviewing. In addition, the staff will assist participants in troubleshooting any adherence issues and give participants additional encouragement and support when adherence problems arise. If a participant adheres to meal timing protocol < 4 days/week, a follow-up call or videoconference will be scheduled to address challenges and to counsel participants. Furthermore, In order to reduce participant burden, if at all possible study procedures will be scheduled to coincide with participants' scheduled clinical visits.

(7) To further inform future trials and scalability we will continuously collect recruitment, consent, and retention rates, and barriers to engagement.

(8) Adverse Event Monitoring will be monitored. If at any time, the study staff notices any unhealthy compensatory behaviors the PI will be notified and a treatment plan will be created to ensure that the participant receive the appropriate screening, work-up, and diagnosis from their primary care provider and are withdrawn from the study if appropriate.

(9) The PI and research team will meet bi-weekly to monitor all study procedures and oversee data management and analysis.

公式タイトル

Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)

疾患/病気
小児肥満2型糖尿病時間制限食
その他の研究識別子
NCT番号
開始日
2023-04-15
最終更新日
2025-06-24
終了予定日
2027-12-01
目標参加者数
100
試験の種類
介入研究
治験の相・段階
該当なし
状況
募集中
キーワード
Intermitted-fasting
Type 2 Diabetes
Time Limited Eating
主目的
治療
割付方法
無作為化
介入モデル
並行割当
盲検化
単盲検
群(アーム)/介入
参加グループ/群介入/治療法
実験的Control: 12 hour eating period
Control: Habitual daily eating period (no meal time restrictions)
Components Common to All Study ARMS.
All participants will receive two hours of standard nutrition counseling recommended for adolescents living with T2D. No specific caloric restriction will be recommended. All participants will maintain their usual lifestyle, including physical activity and sleep patterns. Physical activity and sleep recommendations consistent with the American Academy of Pediatrics guidelines for adolescents will be encouraged but not formally prescribed.
コントロール
Participants assigned to the control arm will be instructed to consume food over a 12-h or more eating window. No energy restriction will be required.
持続血糖モニター
All participants will be trained to wear a blinded continuous glucose monitor sensor using manufacturer educational materials under the supervision of research staff. Participants will be asked to wear the CGM for the duration of the study. During each study visit, the CGM reader will be connected to the site database to create an individual participant report. Participants will be provided enough sensors to replace the sensor every 14 days. The participants and guardians will be educated on how to use the CGM and receive 1:1 coaching on how to change the sensor, which will be completed either independently or under study team guidance. At each weekly phone meeting, study staff will monitor any challenges related to CGM wear, including participant discomfort, skin adherence, and other issues.
実験的Time Limited Eating
Time Limited Eating: 8-hour eating period (16 hours of daily fasting).
Time Limited Eating
The TLE intervention arm will involve instructing participants to consume their usual kind and amount of food and beverages (all calories) within a pre-specified 8-hour period, fasting for the remaining 16-hours. They will be free to divide their food and beverage intake into as many meals or snacks as desired during the 8-hour period. Participants will be allowed to consume non-caloric beverages (water, tea, coffee) during the fasting period. No energy restriction will be required.
Components Common to All Study ARMS.
All participants will receive two hours of standard nutrition counseling recommended for adolescents living with T2D. No specific caloric restriction will be recommended. All participants will maintain their usual lifestyle, including physical activity and sleep patterns. Physical activity and sleep recommendations consistent with the American Academy of Pediatrics guidelines for adolescents will be encouraged but not formally prescribed.
持続血糖モニター
All participants will be trained to wear a blinded continuous glucose monitor sensor using manufacturer educational materials under the supervision of research staff. Participants will be asked to wear the CGM for the duration of the study. During each study visit, the CGM reader will be connected to the site database to create an individual participant report. Participants will be provided enough sensors to replace the sensor every 14 days. The participants and guardians will be educated on how to use the CGM and receive 1:1 coaching on how to change the sensor, which will be completed either independently or under study team guidance. At each weekly phone meeting, study staff will monitor any challenges related to CGM wear, including participant discomfort, skin adherence, and other issues.
主要評価項目
評価指標指標の説明時間枠
Change in percent time in range
Change in percent time in range, as measured on CGM over the study period
Measured at week 0,4, 12
Change in Hemoglobin A1c
Change in hemoglobin A1c at week 12 compared to baseline
Week 12 compared to baseline
Change in insulinogenic index
Change in insulinogenic index after mixed meal tolerance test
Week 12 compared to baseline
Change in total body fat mass (kg)
Change in total body fat mass as measured by DEXA at week 12 compared to baseline
Week 12 compared to baseline
副次評価項目
評価指標指標の説明時間枠
ASA 24 Dietary Recall
Twenty-four-hour dietary recalls will be conducted for all participants pre- and post-intervention. One weekday and one weekend day will be collected for all participants.
Measured at week 0,4, 12
International Physical Activity Questionnaire (IPAQ)
The International Physical Activity Questionnaire (IPAQ) has been developed to estimate levels of habitual physical activity across different countries and socio-cultural environments and will be collected at 5 time points.
Measured at week 0,4, 12
Munich Chronotype Questionnaire for children and adolescents (MTCQ)
The Munich ChronoType Questionnaire (MCTQ) is a self-rated scale to assess sleep structure, patterns, duration, and quality and will be collected at 5 time points.
Measured at week 0,4, 12
Pittsburg Sleep Quality Index
PSI self-reported sleep scale of quality and quantity
Measured at week 0,4, 12
Change in BMI in excess of the 95th percentile (%BMIp95)
Change in %BMIp95
Measured at week 0,4, 12
適格基準

対象年齢
小児, 成人
試験の最低年齢
12 Years
対象性別
全て

(1) previous diagnosis of Prader-Willi Syndrome, brain tumor or hypothalamic obesity; (2) serious developmental or intellectual disability; (3) previous diagnosis or subthreshold symptoms of an eating disorder (anorexia nervosa, bulimia nervosa, binge-eating disorder); (4) parent/guardian-reported physical, mental of other inability to participate in the assessments (e.g., inability to wear CGM, inability to undergo imaging testing without sedation); (5) previous or planned bariatric surgery; (6) current planned use of an anti-obesity or other diabetes medication (e.g., phentermine, topiramate, orlistat, glucagon-like-peptide-1 agonist, naltrexone, or bupropion); or (7) current participation in other interventional weight loss studies.
Children's Hospital Los Angeles logoChildren's Hospital Los Angeles
責任者
Alaina P. Vidmar, MD, 研究責任者, Assistant Professor of Pediatric, Pediatric Endocrinologist, Children's Hospital Los Angeles
試験中央連絡先
連絡先: Alaina Vidmar, MD, 323-361-3385, [email protected]
連絡先: Gisell Figueroa, 323-361-4664, [email protected]
1 1カ国の場所

California

Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States
Alaina P Vidmar, MD, 連絡先, 323-361-3385, [email protected]
募集中